Welcome to our dedicated page for Well Health Tech news (Ticker: WHTCF), a resource for investors and traders seeking the latest updates and insights on Well Health Tech stock.
WELL Health Technologies Corp. reports developments across a Canadian outpatient healthcare platform, digital health software and related technology-enabled services. The company operates a large owned clinic network in Canada and reports recurring updates on patient visits, Canadian Patient Services, primary care and specialty care performance, acquisitions, clinic transformation activity and financial results.
WELL’s news also covers WELLSTAR healthcare technology products, including electronic medical records, AI-powered clinical tools, patient engagement, eReferral and IT managed services. Other recurring themes include HEALWELL AI, CYBERWELL cybersecurity services, virtual cardiology through CardiologyNow, partnerships for remote cardiac monitoring, conference participation and financing capacity for the company’s healthcare operations.
WELL Health (OTCQX: WHTCF) issued a corporate update on majority-owned Circle Medical, highlighting patient access growth and a legal resolution.
Circle Medical now serves 32 states, connects to 99 payers and ~14,000 health plans, has more than tripled commercially insured patient eligibility, and resolved a USAO billing matter for USD$3.3 million within prior provisions.
WELL Health (OTCQX: WHTCF) appointed Dr. Andrew Bond as Chief Health Officer and Head of Public Sector, effective immediately. He will oversee clinical governance, public sector growth, and responsible technology deployment across WELL’s national care and technology platform, including WELL Canadian Clinics, WELLSTAR and HEALWELL AI.
WELL Health (OTCQX:WHTCF, TSX:WELL) reached its $100 million annualized Adjusted EBITDA run-rate target for WELL Canada three calendar quarters earlier than planned, on about $700 million revenue, implying roughly 14% Adjusted EBITDA margin, about 180 bps above prior guidance.
On June 1, 2026, WELL closed two immediately accretive Canadian clinic acquisitions, OID Group and a 65% interest in UnionMD, for about $115 million at closing, with total consideration potentially up to $160 million. These assets produced about $22 million Adjusted EBITDA in 2025 with margins above 25%, lifting WELL Canadian Clinics to well over $80 million annualized Adjusted EBITDA and expanding the network to roughly 270 clinics and 2,350 billable providers.
Both deals were funded from cash and existing credit facilities. Based on current performance and these acquisitions, WELL now expects to exceed the top end of its prior 2026 Adjusted EBITDA guidance range of $175–$185 million and plans a formal outlook update with Q2 2026 results.
WELL Health (OTCQX: WHTCF) appointed healthcare executive Derek Clark as Chief Operating Officer, effective immediately. Clark brings over 20 years of leadership across digital health, diagnostic imaging, clinical services, and healthcare technology, with prior senior roles at Calian Group and GE Healthcare.
As COO, he will report to CEO Hamed Shahbazi and focus on operational execution, scalability, integration, and enterprise performance management across WELL's healthcare and digital health portfolio.
WELL Health (TSX: WELL, OTCQX: WHTCF) received TSX approval for a renewed Normal Course Issuer Bid (NCIB) and entered an automatic share purchase plan (ASPP) with a broker.
The NCIB allows repurchase of up to 12,770,172 shares (5% of 255,408,705) from May 21, 2026 to May 20, 2027, with daily TSX purchases capped at 383,933 shares. All repurchased shares will be cancelled.
WELL Health (OTCQX: WHTCF) reported Q1 2026 revenue of $368.3M, up 25% year-over-year, with Adjusted EBITDA of $43.1M (12% margin). Canadian Patient Services revenues rose 30% to $130.3M, and total patient visits reached 1.9M (+17% YoY). The company reaffirmed 2026 guidance: $1.55–1.65B revenue and $175–185M Adjusted EBITDA, and noted a Canadian clinics run rate exceeding $500M.
WELL Health Technologies (TSX: WELL / OTCQX: WHTCF) will release Fiscal Q1 2026 results for the period ended March 31, 2026, after market close on Thursday, May 7, 2026. A conference call and simultaneous webcast are scheduled the same day at 5:00 PM ET / 2:00 PM PT.
Management participants include Hamed Shahbazi, Chairman and CEO, and Eva Fong, CFO. Dial-in details and webcast registration are provided for investors and analysts.
WELL Health (OTCQX: WHTCF) reported record Canadian performance in Q1-2026: ~1.27 million patient visits (33% YoY, 13% organic) and Primary Care Adjusted EBITDA margins of ~8%, up ~200 basis points year-over-year. Affiliate clinics expanded to 74 locations and the provider base reached 3,158.
CardiologyNow virtual consultations grew 65% YTD; results are preliminary and subject to final reporting and adjustment.
WELL (OTCQX: WHTCF) subsidiary CYBERWELL launched its CYDEcore™ Fusion platform and announced a unified operating model consolidating Cycura, Seekintoo, and Proack into one cybersecurity business.
Key milestones include SOC2 Type I certification, Microsoft Security Solutions Partner designation, and an XSOAR-based managed security platform with multiple enterprise clients live.
WELL Health Technologies (OTCQX: WHTCF) and majority-owned subsidiary WELLSTAR will present at the 2026 Bloom Burton & Co. Healthcare Investor Conference in Toronto on April 21-22, 2026.
WELL presents April 22 at 9:30-10:00 AM ET (Room 104 C/D, presenter Hamed Shahbazi). WELLSTAR presents April 22 at 10:30-11:00 AM ET (Room 104 C/D, presenter Amir Javidan). Both companies will deliver corporate presentations and hold one-on-one investor meetings.